Related Experiment Video
Updated: Jun 12, 2026
10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Structural analysis of botulinum neurotoxin type G receptor binding
John Schmitt1, Andrew Karalewitz, Desirée A Benefield
1Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Biochemistry
|May 29, 2010
Summary
Botulinum neurotoxin (BoNT) uses dual receptors on neurons, varying by type. BoNT/B and BoNT/G bind specific synaptotagmin proteins and a ganglioside, revealing distinct receptor interactions.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Botulinum neurotoxin (BoNT) targets peripheral neurons at the neuromuscular junction.
- BoNT binding involves a dual-receptor mechanism with gangliosides and proteins.
- Receptor identity differs across BoNT serotypes (A-G).
Purpose of the Study:
- To investigate the specific receptor interactions of Botulinum neurotoxin serotypes B and G.
- To elucidate the roles of synaptotagmin (Syt) isoforms and ganglioside G(T1b) in BoNT binding.
- To provide structural context for understanding BoNT-receptor interactions.
Main Methods:
- Analysis of Botulinum neurotoxin serotype B and G binding to synaptotagmin I and II.
- Investigation of binding to ganglioside G(T1b).
- Utilizing the crystal structure of the BoNT/G receptor-binding domain.
Main Results:
- Botulinum neurotoxin/B and Botulinum neurotoxin/G bind the luminal domains of synaptotagmin I and II.
- Botulinum neurotoxin/B binds both Syt isoforms, while Botulinum neurotoxin/G binds only Syt I.
- Both serotypes were observed to bind ganglioside G(T1b).
Conclusions:
- The study clarifies distinct receptor usage by Botulinum neurotoxin serotypes B and G.
- Understanding these interactions is crucial for elucidating the physiological roles of Syt isoforms.
- The BoNT/G crystal structure offers insights into neurotoxin binding mechanisms.
Related Concept Videos
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...